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Preventing renal disease: The ethnic challenge in the United derived from ethnic communities. For instance, in Brent
Kingdom. in London, 54% of the population is from a non-white
background, of which the largest group is Gujarati Indian
(23%). The Hammersmith Renal Unit serves, among
It has been recognized for some years that migrants others, the population of Southall that is 66% ethnic, of
to the United Kingdom (UK) from the Caribbean and whom 58% are Punjabi Indian in origin. It is worth
the Indian subcontinent have a greatly increased risk emphasizing that the ethnic communities have a much
of end-stage renal failure (ESRF) compared with white younger age structure than the Caucasian community,
Caucasians [1]. This is now impacting on renal services in and since renal failure from all-causes rises with age, the
urban areas with large ethnic communities. Importantly, incidence seen currently is set to rise still further [3].
ethnic patients also are less likely to receive a renal
transplant. Hence, there is a rising number of patients
IMPACT ON DIALYSIS PROGRAMSfrom ethnic communities in many UK renal units. It has
recently been recognized that identifying the factors that Several studies have now demonstrated that the inci-
contribute both to renal disease, and the way it is man- dence of ESRF among individuals from ethnic communi-
aged, will be key to reducing ESRF in these communities. ties is three to five times greater than among Caucasians.
Some of the most recent data comes from a London
renal unit where the take on rates for individuals fromDEMOGRAPHICS
one borough were determined. That study showed the
In the UK, the key groups of individuals who are take on rate/106 adult population/year was 58 for white-
affected are African Caribbeans and those from the In- Caucasians, 221 for South Asians and 163 for African
dian Subcontinent (including those from South Asian - Caribbeans during the period of 1994 to 1997 [4]. This
India, Pakistan and Bangladesh) often via migration was a minimum estimate as patients from this particular
from East Africa. The African Caribbean community in borough were also dialyzed at other units. Importantly,
the UK largely derived from waves of immigration in since all dialysis programs in the UK have grown in size,
the 1950s and 1960s, while the South Asia immigrants this disproportion reflects not only in increased propor-
started to arrive in the late 70s. More recently there has tion of ethnic patients on dialysis, but also a huge increase
been a growing population of African migrants, espe- in the absolute numbers.
cially from areas such as Somalia and Sudan. In the 1991 If the US is used as a benchmark for unrestricted
England census, the first to formally record ethnicity, access to dialysis, then despite the excess take on rates,
3% of the adult population was Asian and 1.9% African it is likely there is a great deal of unmet need in the
Caribbean. When the ethnicity of all dialysis patients in
ethnic communities in the UK. The total take on rate in
England was examined for the same year, 7.7% were
the US is 350/106 adult population/year and nearly
Asian and 4.7% African Caribbean [2]. Local demo-
1000/106 adult population/year when African Americansgraphics are much more striking with some boroughs
alone are studied. Despite markedly lower take on ratesin London having more than 50% of their population
than these, most renal units in the UK are now working
to capacity. If the system is to avoid meltdown, two
objectives need to be met: an increase in the rate of trans-Key words: kidney disease in UK, end-stage renal disease, dialysis,
transplantation, ethnic minorities, NKF ABLE. plantation for those on dialysis and, more importantly,
a reduction in the incidence of ESRF. There are approxi- 2003 by the International Society of Nephrology
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mately 15,000 individuals with functioning transplants in If these problems are not addressed, the numbers of
ethnic patients on dialysis programs will continue to rise,the UK and 16,000 on dialysis, of whom only 6000 are
considered fit enough to be on the UK transplant waiting and are likely to be accompanied by high rates of co-
morbidity due to other diabetic complications as well aslist. It is reasonable to assume that these numbers repre-
sent the tip of an iceberg comprising those with progres- those due to hypertension and late treatment.
sive renal failure, those with overt renal disease and those
at risk of renal disease. However, there are virtually no
WHY ACT NOW?data available on the numbers in each of these groups
Until relatively recently, a therapeutic nihilism pre-or of the proportions from ethnic communities.
vailed when considering the outlook for diabetic ne-
phropathy and indeed, progressive renal impairment of
CAUSES OF RENAL FAILURE IN UK any cause. This gloomy outlook has been countered by
ETHNIC COMMUNITIES the weight of several recent studies providing evidence
Type 2 diabetes mellitus and hypertension are the that most forms of renal impairment can be prevented
two of the most common causes. In some South Asian or delayed [7]. The reduction in personal cost and costs
communities more than 20% of the adult population is to the NHS cannot be overestimated, particularly when
diabetic. Worse, several studies have demonstrated an considering that each patient-year on dialysis costs a
increased susceptibility to diabetic nephropathy [re- minimum of 25,000UKP.
viewed in 5]. Hypertension has long been recognized as Type 2 diabetes mellitus can be prevented in high risk
a major cause of ESRF in African Caribbeans, but it is individuals by relatively simple measures [8]; microalbu-
also a significant contributor to renal disease in the South minuria in diabetics can be delayed or prevented; many
Asian community. Recent data have confirmed earlier renal diseases are amenable to specific therapy, and the
observations that the South Asian populations may be use of angiotensin converting enzyme inhibitors, or an-
especially susceptible to interstitial nephritis, the cause giotensin 2 receptor blockers, can delay or prevent the
of which remains unclear. This is an important cause of progression of diabetic and non-diabetic renal disease
renal failure, not only because it leads to excess ESRF [9, 10]. Perhaps most importantly, the onset of ESRF
among South Asian women, but also because it has an can be delayed even in those with quite advanced renal
insidious onset without marked hypertension, protein- impairment. All of these data suggest that early diagnosis
uria or hematuria, and hence tends to present with ad- of those at risk and those with renal disease are likely
vanced renal failure [4]. Screening for markers of tubular to benefit. Since the rates of ESRF are so high in the
damage, such as retinol binding protein, may allow ear- ethnic communities, it seems self-evident that these should
lier detection of this condition. Overall there are likely be the groups to target in the first instance.
to be both genetic and environmental factors that con-
tribute to the susceptibility of most ethnic communities
CHANGING THE OUTLOOKto nephropathies and renal failure [5].
Regardless of pathology, there are other factors con- The issue of reducing the excess renal disease and
renal failure in ethnic communities can be addressed attributing to the excess of ESRF among ethnic communi-
ties in the UK. In particular, possible delays in diagnosis several levels. In the first instance it is important to
ensure that best practice with respect to blood pressureand referral due to impaired access/uptake of health
care. There needs to be an analysis of the patient pathway and diabetes care are implemented for all patients. This
will require increased understanding of renal disease notto clarify where the problems arise. Some have suggested
that individuals from the South Asian community are only among at-risk communities, but also among primary
and secondary health care providers. Reducing inequali-more likely to attend a community diabetic clinic than
one that is hospital based (G. Rhandawa, University of ties in health is a government priority in the UK. An im-
portant development is the establishment of a NationalLuton, personal communication). Others have shown
that patients do get referred to nephrologists/diabetolo- Service Framework for Renal Disease. This is currently
at the consultation phase and it is hoped that issuesgists relatively early, but are then lost to follow-up until
they present with ESRF [6]. It is critical to identify the relevant to individuals from ethnic communities will be
addressed in each of the modules: Effective Delivery oflevel of understanding of renal disease among individuals
from different ethnic communities, whether there are Dialysis, Transplantation, Primary Prevention and Pre-
Dialysis, and Alternative Models of Care.anxieties about stigmatization or if language is a major
barrier, and to generally understand the health care be- As already discussed, studies need to identify how
ethnic patients at risk of, or with renal disease, travelliefs of different groups. By studying the attitudes and
barriers to healthcare it will be possible to define a cultur- through the health care system from primary to second-
ary to tertiary care. Such analyses will identify deficitsally competent service for different at-risk communities.
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in the provision of care specific to ethnic communities, impairment among ethnic patients and the value of dif-
ferent interventions.and suggest strategies that could improve access.
There is debate over the contribution of genetic andWhile an important aim must be to reduce renal fail-
environmental influences on renal disease in ethnic indi-ure, there are already large numbers of ethnic patients
viduals. If suitable numbers of patients and controls canon dialysis, and these are much less likely to receive a
be identified, undoubtedly it will be worthwhile to gatherrenal transplant than Caucasians. Recent data suggests
DNA, and the possibility of establishing a national DNAthat ethnic patients are just as likely to be placed on
bank is being explored. The influence of the environmentwaiting lists as white Caucasians, but that they wait much
is perhaps harder to address, but there are several inter-longer for a transplant, and may be at increased risk of
esting questions to pursue, including the influence ofdying with a functioning graft [6]. The excess death rate
birth weight and nephron number, and the contributionhas not been looked at prospectively and may reflect
of heavy metal toxicity.increased co-morbidity. Clearly this needs to be studied
further. Transplants in the UK are allocated primarily
on best match, and the lack of donors from ethnic com- THE NKRF ABLE INITIATIVE
munities disadvantages patients from those communi-
The National Kidney Research Fund has establishedties, largely because of the excess of blood group B
the ABLE (“A Better Life”) campaign to address theamong potential recipients. The lack of ethnic donors
issue of renal disease in ethnic communities in the UK.reflects complex issues including possible limitation of
At the outset 2 years ago, the ABLE advisory groupaccess to ICU beds, perceptions and prejudices of staff
established that more than a brief awareness campaignwho may fail to approach the families of possible donors,
was required. As a result, the NKRF commissioned aas well as deeply held cultural beliefs regarding donation.
position paper to highlight what is known about renalImportantly, the leaders of all the major faith groups in
disease in ethnic communities and to outline a strategythe UK support cadaveric donation and offer no religious
for tackling the key issues [5]. This has led to fundingbarriers. There are now active campaigns, initiated by
from the Department of Health, The Community fundthe Department of Health and being undertaken by UK
and other sources to support research programs, initiallyTransplant (UKT), to raise awareness of the need for
in one or two national centers, aimed at increasing aware-donors from ethnic communities and to promote live
ness among local ethnic communities, evaluating thedonation.
benefit of screening for renal disease and assessing pa-
An important element in ensuring equality of access
tient pathways. The program was recently launched by
and implementation of change is accurate knowledge of
a week’s evaluation of the effectiveness of various modes
the numbers of individuals at risk. Many renal units still
of advertising to encourage individuals from an ethni-
do not record ethnicity and it is not yet a compulsory
cally diverse London Borough to attend awareness and
element for submission of data to the UK Renal Registry, screening sessions. At all stages, a key part of the ABLE
though it is now recorded by UKT for transplant waiting strategy will be to involve local health care workers in
lists. It would be advantageous to establish a register of order to inform and raise awareness of current best prac-
pre-dialysis patients, again with accurate ethnicity re- tice. An important byproduct of the ABLE initiative
cording. These records would facilitate audit of the pa- has been to bring together a national multidisciplinary
tient pathway and, critically, effective modeling of the network of individuals who are already beginning to
need for renal service provision. There is a precedent in develop collaborative projects focused on renal disease
primary care where chronic disease registers, covering in ethnic communities.
diabetes and hypertension, have already been estab-
lished in many parts of the UK.
CONCLUSIONSThere is a huge need for research into the issue of
renal disease in ethnic communities in the UK. There The long-term aim must be to reduce the number of
are few data on the value of screening for early renal individuals from ethnic communities reaching ESRF by
disease and, in particular, how to focus this in order to earlier identification and implementation of effective
ensure an optimal cost/benefit ratio. Data from the Afri- treatment. Where prevention is unsuccessful, then we
can American community in the US suggest that targeting must ensure that those who require renal support are
family members of those with renal disease may identify referred in a timely and planned manner. The issue of
high numbers of at risk individuals [11]. We still do not renal disease in ethnic communities highlights problems
know which is the best screening test. There is debate facing all of nephrology such as the efficacy of screening
over the best way to screen for diabetes, let alone identi- and interventions. However, by focusing on changing
fying silent tubulointerstitial disease! Prospective studies the outlook for high-risk ethnic groups, it is likely that
the wider community also will benefit. If we fail to tackleare needed to establish the natural history of early renal
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